Doctors' Real-World choices for gut disease treatment tracked
NCT ID NCT04989907
Summary
This study observed how doctors in Switzerland treat adults with Crohn's disease or ulcerative colitis using the medicine vedolizumab. Researchers watched whether patients received the drug as an infusion into a vein or as an injection under the skin, and tracked how long they stayed on treatment. The goal was to understand real-world treatment patterns, not to test a new cure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHNS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bauchzentrum INSELSPITAL, Universitatsspital Bern
Bern, 3010, Switzerland
-
Clarunis AG
Basel, 4002, Switzerland
-
Gastroenterologische Praxis Balsiger, Seibold & Partner Crohn-Colitis-Zentrum
Bern, 3012, Switzerland
-
Kantonsspital St. Gallen
Sankt Gallen, Canton of St. Gallen, 9007, Switzerland
-
Universitatsspital Zurich
Zurich, 8091, Switzerland
-
Zentrum fur Gastroenterologie und Hepatologie AG
Zurich, 8048, Switzerland
Conditions
Explore the condition pages connected to this study.